These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 814956)

  • 21. [Metabolic control and insulin secretion in diabetic patients treated with glibenclamide-phenformin combination].
    Fedele D; Tiengo A; Muggeo M; Garotti C; Crepaldi G
    Clin Ter; 1975 Nov; 75(3):273-80. PubMed ID: 819203
    [No Abstract]   [Full Text] [Related]  

  • 22. [The glibenclamide-phenformin combination in the therapy of diabetes mellitus].
    Postiglione F; Verdoliva A; Schiraldi F
    Clin Ter; 1974 Jul; 70(2):147-51. PubMed ID: 4212848
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparative effects of phenformin, metformin and glibenclamide on metabolic rhythms in maturity-onset diabetics.
    Nattrass M; Todd PG; Hinks L; Lloyd B; Alberti KG
    Diabetologia; 1977 Apr; 13(2):145-52. PubMed ID: 404205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucose disturbances and regulation with glibenclamide in thalassemia.
    Ladis V; Theodorides C; Palamidou F; Frissiras S; Berdousi H; Kattamis C
    J Pediatr Endocrinol Metab; 1998; 11 Suppl 3():871-8. PubMed ID: 10091160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of glibenclamide treatment on insulin secretion and on insulin binding to erythrocytes in type II diabetes mellitus.
    Araujo LM; Ursich MJ; Pupo AA; Fukui RT
    Braz J Med Biol Res; 1988; 21(1):35-42. PubMed ID: 3140992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Plasma insulin and glucose levels in diabetics treated with glibenclamide and chlorporpamide].
    Aiello C; Turner D; Aparicio NJ; De Turner EA; Vazquez A
    Acta Diabetol Lat; 1973; 10(1):30-53. PubMed ID: 4197367
    [No Abstract]   [Full Text] [Related]  

  • 27. The effects of phenformin on peripheral glucose utilization and insulin action in obesity and diabetes mellitus.
    Butterfield WJ
    Ann N Y Acad Sci; 1968 Mar; 148(3):724-33. PubMed ID: 5242146
    [No Abstract]   [Full Text] [Related]  

  • 28. [Controlled clinical study of a new oral antidiabetic formed by a glibenclamide-phenformin association].
    Torri A; Zanni A
    Clin Ter; 1974 Aug; 70(3):236-57. PubMed ID: 4214456
    [No Abstract]   [Full Text] [Related]  

  • 29. Carbohydrate-induced hypertriglyceridemia: inhibition by phenformin.
    Owen WC; Kreisberg RA; Siegal AM
    Diabetes; 1971 Nov; 20(11):739-44. PubMed ID: 5115588
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of glibenclamide on the glucose and insulin profile in maturity onset diabetics following both acute and long term treatment.
    Owens DR; Biggs PI; Shetty KJ; Wragg KG
    Diabete Metab; 1980 Sep; 6(3):219-24. PubMed ID: 6777211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of glibenclamide therapy on carbohydrate and lipid metabolism and insulin secretion in patients with glucose tolerance disorders : a 5-year study].
    Ratzmann KP; Witt S; Schulz B; Jahr D; Heinke P
    Z Gesamte Inn Med; 1981 Dec; 36(23):913-7. PubMed ID: 6805141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Influence of a new oral hypoglycemic product (glibenclamide-phenformin) on some aspects of lipid metabolism].
    Ceruso D; Squadrito G; Emanuele M; Quartarone M; Bellinghieri G
    Boll Soc Ital Biol Sper; 1973 Nov; 49(22):1285-9. PubMed ID: 4212680
    [No Abstract]   [Full Text] [Related]  

  • 33. [Therapy of diabetes with oral hypoglycemic agents. Controlled clinical study of 2 glibenclamide-phenformin combinations. I].
    Uccella R
    Clin Ter; 1978 Nov; 87(4):375-83. PubMed ID: 109242
    [No Abstract]   [Full Text] [Related]  

  • 34. [Study on biological characteristics of spontaneous diabetic KK mice].
    Chen QM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Dec; 10(6):416-20. PubMed ID: 2978397
    [No Abstract]   [Full Text] [Related]  

  • 35. Extrapancreatic insulin effect of glibenclamide.
    Mulder H; Schopman W; van der Lely AJ
    Eur J Clin Pharmacol; 1991; 40(4):379-81. PubMed ID: 1904820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prevalence of type II diabetes mellitus in population of Krakow].
    Szurkowska M; Szybiński Z; Nazim A; Szafraniec K; Jedrychowski W
    Pol Arch Med Wewn; 2001 Sep; 106(3):771-9. PubMed ID: 11928585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of overweight diabetics with a combination of glibenclamide and phenformin].
    Palmieri G; Alkabes M
    Clin Ter; 1977 Jun; 81(6):537-46. PubMed ID: 407046
    [No Abstract]   [Full Text] [Related]  

  • 38. Increased insulin sensitivity and cellular insulin binding in obese diabetics following treatment with glibenclamide.
    Beck-Nielsen H; Pedersen O; Lindskov HO
    Acta Endocrinol (Copenh); 1979 Mar; 90(3):451-62. PubMed ID: 106617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the predictive power for overall blood glucose control of a 'good' fasting level in type 2 diabetic patients on diet alone or with oral agents.
    Trovati M; Burzacca S; Mularoni E; Massucco P; Cavalot F; Mattiello L; Anfossi G
    Diabet Med; 1992 Mar; 9(2):134-7. PubMed ID: 1563247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response of regimens of insulin therapy in type 2 diabetes mellitus subjects with secondary failure.
    Zargar AH; Masoodi SR; Laway BA; Wani AI; Bashir MI
    J Assoc Physicians India; 2002 May; 50(5):641-6. PubMed ID: 12186116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.